
Name
Allovectin-7
Alternate Names
None
Abbreviations
None
Category
Biologic therapy (BRM, immunotherapy)
Subcategory
Gene therapy
NSC Number
None
Primary Site
Histology
None
Remarks
Phase II, Phase III metastatic melanoma Increases the ability of the immune system to recognize cancer cells and kill them. Gene based immunotherapy. Vical, Inc.
Coding
This drug should be coded
